FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

422456007: Ranibizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2641602015 Ranibizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2645708017 Ranibizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2641602015 Ranibizumab (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2641602015 Ranibizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2645708017 Ranibizumab en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2645708017 Ranibizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
374721000195110 ranibizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
193211000077112 ranibizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
193211000077112 ranibizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
374721000195110 ranibizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranibizumab (substance) Is a agent d'anticorps monoclonal false Inferred relationship Existential restriction modifier (core metadata concept)
Ranibizumab (substance) Is a Angiogenesis inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Ranibizumab (substance) Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Ranibizumab (substance) Has disposition Angiogenesis inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Ranibizumab (substance) Has disposition Vascular endothelial growth factor receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Ranibizumab (substance) Is a Vascular endothelial growth factor receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ranibizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ranibizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Ranibizumab 10mg/mL solution for intravitreal injection 0.05mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranibizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Uveitis caused by ranibizumab (disorder) Causative agent (attribute) False Ranibizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Ranibizumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ranibizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Ranibizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Ranibizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Ranibizumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ranibizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Ranibizumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ranibizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Uveitis caused by ranibizumab (disorder) Causative agent (attribute) True Ranibizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start